(S)-N-((S)-6-((S)-2-((1H-indol-3-yl)methyl)-3-methoxy-5-oxo-2,5-dihydro-1H-pyrrol-1-yl)-6-oxo-1-phenylhex-4-en-3-yl)-2-((S)-2-((S)-2-(dimethylamino)-3-methylbutanamido)-4-methylpentanamido)-4-methylpentanamide

ID: ALA4596647

PubChem CID: 155513745

Max Phase: Preclinical

Molecular Formula: C45H62N6O6

Molecular Weight: 783.03

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COC1=CC(=O)N(C(=O)/C=C/[C@H](CCc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C(C)C)N(C)C)[C@H]1Cc1c[nH]c2ccccc12

Standard InChI:  InChI=1S/C45H62N6O6/c1-28(2)23-36(48-44(55)37(24-29(3)4)49-45(56)42(30(5)6)50(7)8)43(54)47-33(20-19-31-15-11-10-12-16-31)21-22-40(52)51-38(39(57-9)26-41(51)53)25-32-27-46-35-18-14-13-17-34(32)35/h10-18,21-22,26-30,33,36-38,42,46H,19-20,23-25H2,1-9H3,(H,47,54)(H,48,55)(H,49,56)/b22-21+/t33-,36-,37-,38-,42-/m0/s1

Standard InChI Key:  QTDXHJIDZCYDHI-UOIWUHIWSA-N

Molfile:  

     RDKit          2D

 57 60  0  0  0  0  0  0  0  0999 V2000
   22.9253  -18.8003    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.6420  -19.2128    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.3565  -18.8003    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.6420  -20.0378    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   22.2131  -19.2128    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.4986  -18.8003    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.7841  -19.2128    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.4986  -17.9753    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.0697  -18.8003    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.3551  -19.2128    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.3551  -20.0378    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   25.0710  -19.2128    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.7854  -18.8003    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.4999  -19.2128    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.2144  -18.8003    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.9289  -19.2128    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.2144  -17.9753    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   28.0193  -20.0290    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.8263  -20.2005    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.2388  -19.4859    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.6868  -18.8729    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.4077  -20.5827    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   30.0593  -19.3996    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   30.5443  -20.0670    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.8571  -18.0657    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.6413  -17.8096    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.3044  -18.2942    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.9712  -17.8083    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   29.8901  -17.0253    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.7145  -17.0245    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.1243  -16.3112    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.7107  -15.5983    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.8831  -15.6031    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.4771  -16.3169    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6437  -18.8049    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.7841  -20.0378    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.0710  -20.0378    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6414  -17.9798    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9305  -19.2194    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.2190  -18.8090    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9329  -20.0444    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.3547  -17.5652    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9257  -17.5695    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.4962  -20.4503    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.9242  -17.9753    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.6382  -17.5618    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.6371  -16.7368    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.3532  -17.9734    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.4930  -21.2742    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.2073  -20.0389    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.7854  -20.4503    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.7854  -21.2753    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.0677  -21.6845    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.0674  -22.5087    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.7824  -22.9220    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.4993  -22.5050    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.4962  -21.6822    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  3  1  0
  2  1  1  0
  2  4  2  0
  1  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  2  0
  7  9  1  0
  9 10  1  0
 10 11  2  0
  3 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 15 17  2  0
 16 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 16  1  0
 18 22  2  0
 20 23  1  0
 23 24  1  0
 21 25  1  1
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 30  1  0
 29 26  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 33  1  0
 33 34  2  0
 34 29  1  0
 10 35  1  0
  7 36  1  6
 12 37  1  6
 35 38  1  1
 35 39  1  0
 39 40  1  0
 39 41  1  0
 38 42  1  0
 38 43  1  0
 36 44  1  0
  1 45  1  1
 45 46  1  0
 46 47  1  0
 46 48  1  0
 44 49  1  0
 44 50  1  0
 37 51  1  0
 51 52  1  0
 52 53  2  0
 53 54  1  0
 54 55  2  0
 55 56  1  0
 56 57  2  0
 57 52  1  0
M  END

Alternative Forms

  1. Alternative Forms:

    ALA4596647

    ---
  2. Parent:

    ALA4596647

    ---

Associated Targets(Human)

CTSL Tclin Cathepsin L (3852 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CTSB Tchem Cathepsin B (3822 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CTSV Tchem Cathepsin L2 (273 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CTSS Tchem Cathepsin S (3285 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CTSK Tchem Cathepsin K (3011 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

SARS-CoV-2 (38078 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Ctsl Cathepsin L1 (28 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Vero C1008 (1716 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cruzipain (33337 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Trypanosoma cruzi (99888 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
C2C12 (756 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 783.03Molecular Weight (Monoisotopic): 782.4731AlogP: 5.30#Rotatable Bonds: 20
Polar Surface Area: 152.94Molecular Species: NEUTRALHBA: 7HBD: 4
#RO5 Violations: 2HBA (Lipinski): 12HBD (Lipinski): 4#RO5 Violations (Lipinski): 3
CX Acidic pKa: 9.79CX Basic pKa: 8.02CX LogP: 5.94CX LogD: 5.33
Aromatic Rings: 3Heavy Atoms: 57QED Weighted: 0.11Np Likeness Score: 0.49

References

1. Ashhurst AS, Tang AH, Fajtová P, Yoon MC, Aggarwal A, Bedding MJ, Stoye A, Beretta L, Pwee D, Drelich A, Skinner D, Li L, Meek TD, McKerrow JH, Hook V, Tseng CT, Larance M, Turville S, Gerwick WH, O'Donoghue AJ, Payne RJ..  (2022)  Potent Anti-SARS-CoV-2 Activity by the Natural Product Gallinamide A and Analogues via Inhibition of Cathepsin L.,  65  (4.0): [PMID:34730959] [10.1021/acs.jmedchem.1c01494]
2. Barbosa Da Silva E, Sharma V, Hernandez-Alvarez L, Tang AH, Stoye A, O'Donoghue AJ, Gerwick WH, Payne RJ, McKerrow JH, Podust LM..  (2022)  Intramolecular Interactions Enhance the Potency of Gallinamide A Analogues against Trypanosoma cruzi.,  65  (5.0): [PMID:35188371] [10.1021/acs.jmedchem.1c02063]

Source